Thromb Haemost 1963; 09(01): 202-210
DOI: 10.1055/s-0038-1654974
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Fibrinolysis in the Pleural Cavity After Pnlmonary Resection

C. L Zaman M. D.
1   Sanatorium “Berg en Bosch”, Bilthoven, and from the Clotting Department of the Central Laboratory of the Netherlands Red Cross Blood Transfusions Service, Amsterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

Summary

An analysis of the fibrinolytic properties of the pleural exsudate after pulmonary resection revealed that the exsudate contained an excess of an activator of plasminogen during the first 4 hours after completion of the operation. This activator was still present in appreciable amounts until about 20 hours after the resection. The activator possessed the thermostability of tissue activator and was probably released from freshly traumatized tissue.

 
  • References

  • 1 Ablondi F. B, Hagan J. J, Philips M, de Renzo E. C. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by e-aminocaproic acid. Arch. Biochem. 82: 153 1959;
  • 2 Alkjaersig N, Fletcher A. P, Sherry S. 8-aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem. 234: 832 1959;
  • 3 Astrup T. Fibrinolysis in the organism. Blood. 11: 781 1956;
  • 4 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 40: 346 1952;
  • 5 Beumer H. M, Mellema T. L. Excavated haematomas after pulmonary segmental resection. Dis. Chest. 37: 163 1960;
  • 6 Celander D. R, Guest M. M. Assay of canine profibrinolysin (plasminogen). Amer. J. Physiol. 197: 391 1959;
  • 7 Jackson H. D, Mertz E. T. Activation of bovine plasminogen by trypsin. Proc. Soc. exp. Biol. (N. Y) 86: 827 1954;
  • 8 Kowalski E, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J. clin. Path. 12: 215 1959;
  • 9 Lassen M. Heat dénaturation of plasminogen in the fibrin plate method. Acta physiol, scand. 27: 371 1953;
  • 10 Lewis J. H, Ferguson J. H. Studies on a proteolytic enzyme system of the blood. II. Fibrinolysokinase activators for profibrinolysin. J. clin. Invest. 29: 1059 1950;
  • 11 Milstone H. A factor in normal human blood which participates in streptococcal fibrinolysis. J. Immunol. 42: 109 1941;
  • 12 Milwidsky H, Ginsburg I, de Vries A. Studies on fibrinolytic enzymes in patients undergoing thoracic surgery. J. thorac. Surg. 29: 604 1955;
  • 13 Sherry S, Lindemeijer R, Fletcher A. P, Alkjaersig N. Studies on enhanced fibrinolytic activity in man. J. clin. Invest. 38: 810 1959;
  • 14 Thiess H. A. Postoperative Fibrinolyse. Barth, Leipzig: 1960
  • 15 Truelove S. C. The lability of human fibrinolysin. Clin. Sci. 12: 75 1953;
  • 16 Witz J. P, Reys P. h, de Haynin G, Weiss A. G. La thrombophilie postopératoire en chirurgie thoracique (chirurgie cardiaque exceptée) étudiée par la méthode thrombélastographique. Poumon. 15: 357 1959;
  • 17 Zaman C. L. Fibrinolysis na longresectie. Thesis, Amsterdam: 1961